Immunogenicity and Safety of Bivalent Meningococcal Serogroups A and C Tetanus Toxoid Conjugate Vaccine in Chinese
Clinical trial NCT03714737 · COMPLETED
Trial details
- NCT number
- NCT03714737
- Sponsor
- Jiangsu Province Centers for Disease Control and Prevention
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-12
- Primary completion
- 2017-09-11
- Enrollment
- 1950
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.